These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35848630)
1. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy. Londero D; Merluzzi S; Dreossi C; Barillari G Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456 [TBL] [Abstract][Full Text] [Related]
3. Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA. Londero D; Stampalija T; Bolzicco D; Castro Silva E; Candolini M; Cortivo C; Dreossi C; Fantasia I; Pecile V; De Angelis V Transfus Med; 2019 Dec; 29(6):408-414. PubMed ID: 31209986 [TBL] [Abstract][Full Text] [Related]
4. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
6. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. Kent J; Farrell AM; Soothill P BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571 [TBL] [Abstract][Full Text] [Related]
8. High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis. Yang H; Llewellyn A; Walker R; Harden M; Saramago P; Griffin S; Simmonds M BMC Med; 2019 Feb; 17(1):37. PubMed ID: 30760268 [TBL] [Abstract][Full Text] [Related]
9. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138 [TBL] [Abstract][Full Text] [Related]
10. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program. Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus. Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548 [TBL] [Abstract][Full Text] [Related]
12. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium. Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833 [TBL] [Abstract][Full Text] [Related]
13. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland. Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198 [TBL] [Abstract][Full Text] [Related]
14. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation. Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376 [TBL] [Abstract][Full Text] [Related]
15. Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping. Stensrud M; Bævre MS; Alm IM; Wong HY; Herud I; Jacobsen B; de Vos DDJA; Stjern HE; Sørvoll IH; Barane JB; Bagås TE; Rasmussen M; Ulvahaug N; Wamstad V; Tomter G; Akkök CA Fetal Diagn Ther; 2023; 50(4):276-281. PubMed ID: 37379821 [TBL] [Abstract][Full Text] [Related]
16. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. Clausen FB; Steffensen R; Christiansen M; Rudby M; Jakobsen MA; Jakobsen TR; Krog GR; Madsen RD; Nielsen KR; Rieneck K; Sprogøe U; Homburg KM; Baech J; Dziegiel MH; Grunnet N Prenat Diagn; 2014 Oct; 34(10):1000-5. PubMed ID: 24860987 [TBL] [Abstract][Full Text] [Related]